(Q35053207)

6 August 2017

1 reference

title

Examining unmet needs in infectious disease (English)

1 reference

6 August 2017

1 reference

Noel J C Snell

1

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

8

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

22-30

1 reference

Emerging infectious diseases--a therapeutic challenge

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Emerging and re-emerging infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Emerging infectious diseases of wildlife--threats to biodiversity and human health

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

A human disease indicator for the effects of recent global climate change

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Are all diseases infectious? Another look

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Chlamydia protein linked to heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Bornavirus and psychiatric disorders -- fact or fiction?

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Retroviruses and the pathogenesis of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Autoimmunity. The pathogen connection

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Bacterial infection as a cause of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

The AIDS epidemic--considerations for the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: strategies to overcome drug resistance development

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Many HIV patients carry mutated drug-resistant strains

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Viral phenotype and CCR5 genotype

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

New HIV drugs show promise in early studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Avoiding the kiss of death: how HIV and other chronic viruses survive

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

GB virus C and mortality from HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Potential benefit and limitations of a broad access to potent antiretroviral therapy in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Strategies for an HIV vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Lassa fever. Effective therapy with ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Symptomless infection with Ebola virus

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Development of a preventive vaccine for Ebola virus infection in primates

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Virology. Rafting with Ebola

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

The role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination?

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Hantavirus pulmonary syndrome: the new American hemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Prospective, Double-Blind, Concurrent, Placebo-Controlled Clinical Trial of Intravenous Ribavirin Therapy of Hemorrhagic Fever with Renal Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Virology. Finally, a handle on the hantaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Transmissibility from horses to humans of a novel paramyxovirus, equine morbillivirus (EMV)

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Nipah Virus Encephalitis Outbreak in Malaysia

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Hepatitis C-Z: recent advances

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Vaccines to prevent viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Treatment of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Clinical potential of emerging new agents in hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Hepatitis C: molecular virology and antiviral targets

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Peginterferon alpha-2b: a new approach to improving response in hepatitis C patients

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Interferon and ribavirin for patients with chronic hepatitis C who did not respond to previous interferon therapy: a meta-analysis of controlled and uncontrolled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Emerging therapies for hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Human herpesviruses at sixes, sevens, and more.

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Emerging infectious agents: do they pose a risk to the safety of transfused blood and blood products?

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

The injection century: massive unsterile injections and the emergence of human pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Simian virus 40 and human malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Simian virus 40 and non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

The treatment of tuberculosis: current status and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Emerging therapeutic targets in tuberculosis: post-genomic era.

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Viral Trojan horse for combating tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Recent advances in our understanding of human host responses to tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Tuberculosis vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

West Nile virus in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Dengue: an escalating problem

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

The future of dengue vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Management of herpes virus infections following transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Human cytomegalovirus terminase as a target for antiviral chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

New anti-HSV therapeutics target the helicase-primase complex

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

New treatments for viral respiratory tract infections--opportunities and problems

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Influenza vaccines: present and future

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Development of an improved vaccine for anthrax

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Antifungal drug resistance of pathogenic fungi.

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Mechanisms of antimicrobial resistance: their clinical relevance in the new millennium

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

African scientists discuss drug-resistant malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Antibiotic resistance. Livestock feed ban preserves drugs' power

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

https://api.crossref.org/works/10.1016%2FS1359644602025412

1 reference

7 January 2021

Reversing antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Molecular strategies for overcoming antibiotic resistance in bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

The streptogramin antibiotics: update on their mechanism of action.

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Virology. Poliomyelitis eradication--a dangerous endgame

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Leprosy elimination-a virtual phenomenon or a reality?

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Infectious diseases: an ecological perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

Therapeutic vaccines: realities of today and hopes for the future

1 reference

https://api.crossref.org/works/10.1016%2FS1359644602025412

7 January 2021

10.1016/S1359644602025412

Identifiers

DOI

1 reference

6 August 2017

1 reference